The artemisinin sector sees a short-term surge, Rundu Pharma hits the limit up
The artemisinin sector saw a short-term surge, with Rundu Pharma hitting the limit up, followed by gains in Baihua Pharmaceutical, HISUN, ZMC, Kunming Pharmaceutical Group, and CR Double-Crane